download
print

EVENTS & PRESENTATIONS

Upcoming Events

2020 RNAi Roundtable: Lumasiran, in Development for the Treatment of Primary Hyperoxaluria Type I

Listen to Webcast ›

Alnylam Pharmaceuticals Q2 2020 Earnings Conference Call

Listen to Webcast ›

Past Events

2020 RNAi Roundtable: Early Stage RNAi Therapeutics Pipeline

Bank of America Securities 2020 Napa Biopharma Conference

2020 RNAi Roundtable: ALN-AGT, in Development for the Treatment of Hypertension

Goldman Sachs 41st Annual Global Healthcare Conference

Alnylam Pharmaceuticals Conference Call to Discuss Full Results from the ILLUMINATE-A Phase 3 Study of Lumasiran

Looking for specific information that isn't listed above?

Contact: investors@alnylam.com